IL-15-based molecules and methods of use thereof
US11173191B2 · kind B2 · utility
12Cited by
22References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2019 |
| Grant date | Nov 16, 2021 |
| Priority date | — |
| Expiry date | Jun 18, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features combination therapies using an IL-15-based superagonist complex and an antibody to effectively treat subjects with cancer and infectious diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.